Annual FCF
-$117.30 M
+$130.18 M+52.60%
December 31, 2024
Summary
- As of March 10, 2025, ARQT annual free cash flow is -$117.30 million, with the most recent change of +$130.18 million (+52.60%) on December 31, 2024.
- During the last 3 years, ARQT annual FCF has risen by +$58.32 million (+33.21%).
- ARQT annual FCF is now -3007.31% below its all-time high of -$3.77 million, reached on December 31, 2017.
Performance
ARQT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$5.75 M
+$29.08 M+83.50%
December 31, 2024
Summary
- As of March 10, 2025, ARQT quarterly free cash flow is -$5.75 million, with the most recent change of +$29.08 million (+83.50%) on December 31, 2024.
- Over the past year, ARQT quarterly FCF has stayed the same.
- ARQT quarterly FCF is now at all-time high.
Performance
ARQT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$117.30 M
+$50.50 M+30.10%
December 31, 2024
Summary
- As of March 10, 2025, ARQT TTM free cash flow is -$117.30 million, with the most recent change of +$50.50 million (+30.10%) on December 31, 2024.
- Over the past year, ARQT TTM FCF has stayed the same.
- ARQT TTM FCF is now -1516.38% below its all-time high of -$7.26 million, reached on March 31, 2019.
Performance
ARQT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ARQT Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +52.6% | 0.0% | 0.0% |
| 3 y3 years | +33.2% | +87.0% | +55.3% |
| 5 y5 years | -172.0% | +87.0% | +55.3% |
ARQT Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +58.3% | at high | +93.7% | at high | +62.0% |
| 5 y | 5-year | -172.0% | +58.3% | at high | +93.7% | -172.0% | +62.0% |
| alltime | all time | -3007.3% | +58.3% | at high | +93.7% | -1516.4% | +62.0% |
Arcutis Biotherapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$117.30 M(-52.6%) | -$5.75 M(-83.5%) | -$117.30 M(-30.1%) |
| Sep 2024 | - | -$34.83 M(-22.8%) | -$167.80 M(-5.2%) |
| Jun 2024 | - | -$45.12 M(+42.8%) | -$177.02 M(-10.9%) |
| Mar 2024 | - | -$31.60 M(-43.8%) | -$198.66 M(-19.7%) |
| Dec 2023 | -$247.49 M(-11.9%) | -$56.25 M(+27.7%) | -$247.49 M(-5.7%) |
| Sep 2023 | - | -$44.05 M(-34.0%) | -$262.42 M(-15.1%) |
| Jun 2023 | - | -$66.76 M(-17.0%) | -$309.03 M(+1.5%) |
| Mar 2023 | - | -$80.43 M(+13.0%) | -$304.32 M(+8.3%) |
| Dec 2022 | -$281.00 M(+60.0%) | -$71.19 M(-21.5%) | -$281.00 M(+7.3%) |
| Sep 2022 | - | -$90.65 M(+46.1%) | -$261.78 M(+23.4%) |
| Jun 2022 | - | -$62.06 M(+8.7%) | -$212.15 M(+14.1%) |
| Mar 2022 | - | -$57.10 M(+9.9%) | -$185.96 M(+5.9%) |
| Dec 2021 | -$175.62 M | -$51.97 M(+26.7%) | -$175.62 M(+12.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$41.02 M(+14.3%) | -$156.38 M(+4.8%) |
| Jun 2021 | - | -$35.87 M(-23.3%) | -$149.16 M(+7.3%) |
| Mar 2021 | - | -$46.76 M(+42.9%) | -$139.06 M(+22.7%) |
| Dec 2020 | -$113.35 M(+162.8%) | -$32.72 M(-3.2%) | -$113.35 M(+16.3%) |
| Sep 2020 | - | -$33.80 M(+31.1%) | -$97.49 M(+31.0%) |
| Jun 2020 | - | -$25.78 M(+22.5%) | -$74.42 M(+30.7%) |
| Mar 2020 | - | -$21.05 M(+24.8%) | -$56.92 M(+32.0%) |
| Dec 2019 | -$43.13 M(+206.2%) | -$16.86 M(+57.2%) | -$43.13 M(+64.2%) |
| Sep 2019 | - | -$10.73 M(+29.5%) | -$26.27 M(+69.0%) |
| Jun 2019 | - | -$8.29 M(+14.2%) | -$15.54 M(+114.2%) |
| Mar 2019 | - | -$7.26 M | -$7.26 M |
| Dec 2018 | -$14.09 M(+273.1%) | - | - |
| Dec 2017 | -$3.77 M | - | - |
FAQ
- What is Arcutis Biotherapeutics annual free cash flow?
- What is the all time high annual FCF for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual FCF year-on-year change?
- What is Arcutis Biotherapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly FCF year-on-year change?
- What is Arcutis Biotherapeutics TTM free cash flow?
- What is the all time high TTM FCF for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM FCF year-on-year change?
What is Arcutis Biotherapeutics annual free cash flow?
The current annual FCF of ARQT is -$117.30 M
What is the all time high annual FCF for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual free cash flow is -$3.77 M
What is Arcutis Biotherapeutics annual FCF year-on-year change?
Over the past year, ARQT annual free cash flow has changed by +$130.18 M (+52.60%)
What is Arcutis Biotherapeutics quarterly free cash flow?
The current quarterly FCF of ARQT is -$5.75 M
What is the all time high quarterly FCF for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly free cash flow is -$5.75 M
What is Arcutis Biotherapeutics quarterly FCF year-on-year change?
Over the past year, ARQT quarterly free cash flow has changed by $0.00 (0.00%)
What is Arcutis Biotherapeutics TTM free cash flow?
The current TTM FCF of ARQT is -$117.30 M
What is the all time high TTM FCF for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM free cash flow is -$7.26 M
What is Arcutis Biotherapeutics TTM FCF year-on-year change?
Over the past year, ARQT TTM free cash flow has changed by $0.00 (0.00%)